ArticleTheranostics2021

Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.

Chunqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.